InspireMD NSPR 深 沪
等待开盘 08-04 09:30:00 美东时间
2.69
-0.100
-3.58%
华盛通- 最 高2.78
- 今 开2.77
- 成交量 9.75万股
- 最 低 2.59
- 昨 收 2.79
- 总市值 8240.90万
- 52周最高 3.798
- 市盈率 静 --
- 换手率 0.32%
- 52周最低 1.99
- 委 比 94.87%
- 总股本 3063.53万
- 历史最高 27890625.00
- 量 比 0.50
- 振 幅 6.81%
- 历史最低 0.806
- 每 手 1
- 风险率 0.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Soligenix (NASDAQ:SNGX) shares rose 192.0% to $3.65 during Thursday's ...
08-01 01:08
InspireMD shares are trading higher after the company announced it has raised approximately $58 million in gross proceeds through PIPE financing.
InspireMD shares are trading higher after the company announced it has raised a...
07-31 23:09
InspireMD Raises $40.1M in Private Placement Offering
InspireMD ( ($NSPR) ) just unveiled an update. On July 30, 2025, InspireMD ente...
07-31 20:58
InspireMD raises $58M through combined financings; shares up
InspireMD (NASDAQ:NSPR) raised ~$58M through a PIPE financing and warrant exercises. The $40.1M PIPE was led by OrbiMed and Marshall Wace, with participation from board members and other investors. 16...
07-31 20:46
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
InspireMD聘请Raymond W. Cohen为董事会成员，其拥有40年以上医疗科技领导经验，曾成功推动Axonics以37亿美元被Boston Scientific收购。InspireMD近期获FDA批准，即将推出CGuard Prime钴基颈动脉支架系统，Cohen的加入将助力公司加速商业化进程并提升长期价值。
07-31 12:31
InspireMD Announces Combined Financings of $58 Million
InspireMD raised approximately $58 million through a PIPE financing and warrant exercises, triggered by FDA approval of its CGuard Prime carotid stent. The funding was led by investors OrbiMed and Marshall Wace, with proceeds aimed at strengthening the balance sheet and expanding commercial growth in the U.S. market. The company plans to use the funds for sales and marketing, R&D, and general corporate purposes, positioning itself to lead the car...
07-31 12:30
InspireMD to Announce Second Quarter 2025 Financial Results
<p>MIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc., developer of the CGuard® Prime carotid stent system for stroke prevention, will release its second quarter 2025 financial results on August 5, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. Interested parties can access the call via telephone or webcast. A replay will be available on Inspi...
07-22 11:00
InspireMD Launches CGuard Prime Stent in U.S. Market
InspireMD ( ($NSPR) ) has provided an update. On July 9, 2025, InspireMD announ...
07-09 19:28
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
<p>Inspeq News</p> <p>Inspeq has launched the CGuard Prime carotid stent system in the U.S. following FDA approval. The system features a dual-layer design, MicroNet mesh, and SmartFit technology to minimize embolism risk. With double-digit market share in over 30 countries, the company aims to expand its presence in the U.S. using a seasoned commercial team. Experts laud the device for its advanced embolic protection and ease of use, offering ...
07-09 11:00
'Clinical Results of Double-Layer MicroNet Stents in Complex Anatomy'- Science Direct
https://www.sciencedirect.com/science/article/abs/pii/S0890509625004200
07-08 02:30
